On-line CME Education Discusses Lymphoma

OSUWexnerbloglogo2014 On-line CME Education Discusses Lymphoma. Today, Hodgkin’s disease is curable in most patients with a 5-year survival rate of 86%. But this is only one type of lymphoma and as we’ll see today, hematologists have made enormous strides in the management of all types of lymphoma. Joining our moderator are two lymphoma experts from The Ohio State University and the James Cancer Hospital. Dr. Kami Maddocks is an Associate Professor of Internal Medicine from the Division of Hematology. And Dr. Beth Christian is also a hematologist and Associate Professor of Internal Medicine.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: DEFINE the most common types of aggressive lymphomas, identify both urgent initial presentations and urgent complications of treatment, and outline standards of survivorship; and DESCRIBE the features of indolent non-Hodgkin lymphoma including the most common subtypes, follicular lymphoma, marginal zone lymphoma and Waldenström macroglobulinemia.

You’ll also learn about the following:

  • What causes lymphoma
  • The spectrum of lymphomas
  • Stem cell transplant in aggressive lymphomas
  • Whether there a role for “maintenance rituximab”
  • Chronic lymphocytic leukemia versus non-Hodgkin lymphoma
  • Lymphoma mimics
  • Deciding when to biopsy an enlarged lymph node

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Provides Physicians with COPD Update

OSUWexnerbloglogo2014 CME Webcast Provides Physicians with COPD Update. In the 56 years since Sir David Jack invented albuterol, there have been a lot of other treatments developed for COPD. In fact, there are so many that it can be sometimes be overwhelming to know what the best treatment is for any given patient. On this CME webcast, we’re going to discuss how you diagnosis and manage COPD. Joining our moderator, Dr. Jim Allen, in the studio is pulmonologist and Professor of Internal Medicine, Dr. Philip Diaz.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND evidence based guidelines for the management of stable COPD; and UNDERSTAND evidence based guidelines for the management of acute exacerbations of COPD.

You’ll also learn about the following:

  • Societal burden of COPD
  • New developments in COPD
  • Age limits with lung reduction surgery and lung transplant
  • Inhaled steroids and the risk of pneumonia in COPD

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

Care of Transplanted Patients in the Primary Care Clinic

OSUWexnerbloglogo2014 Care of Transplanted Patients in the Primary Care Clinic. More people are getting transplants and they are living longer after transplant. On today’s CME Webcast, we are going discuss what the primary care provider needs to know about the care of transplanted patients in their practice. We’re pleased to welcome nephrologist and Assistant Professor of Internal Medicine, Dr. Alejandro Diez.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: RECOGNIZE the increasing frequency of kidney transplantation in the United States; and IDENTIFY Common Causes for Kidney Transplant Dysfunction.

You’ll also learn about the following:

  • Medical care of the kidney donor
  • Transplant “chains”
  • Dietary restrictions after transplant
  • Skin cancer and anti-rejection medications
  • Managing hypertension in patients taking anti-rejection medications

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

On-line CME Discussing Multiple Myeloma

OSUWexnerbloglogo2014 On-line CME Discussing Multiple Myeloma. In the past year, there have been 4 new drugs approved to treat multiple myeloma and these are changing the way that we manage patients with this disease. On this CME webcast, we’re going to talk about what multiple myeloma is, how you diagnosis it, and how it is treated. Joining our moderator in the studio is hematologist and Assistant Professor of Internal Medicine from the OSU Wexner Medical Center, Dr. Ashley Rosko. And also from the division of hematology, we have Associate Professor of Internal Medicine, Dr. Yvonne Efebera joining us.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: UNDERSTAND the difference between MGUS, smoldering Myeloma, Symptomatic multiple Myeloma; DESCRIBE the general clinical features of plasma cell myeloma including the diagnosis, and steps required for evaluation; UNDERSTAND Treatment strategy for Newly diagnosed Multiple Myeloma Patients Eligible for Transplant and Newly diagnosed Multiple Myeloma Patients not Eligible for Transplant.

You’ll also learn about the following:

  • Epidemiology of multiple myeloma
  • Prognosis of multiple myeloma
  • When to do a bone marrow biopsy?
  • Screening patients with kidney failure for multiple myeloma
  • Management of hypercalcemia and renal failure in multiple myeloma
  • Autologous versus allogenic stem cell transplant

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.

CME Webcast Discusses Acute and Chronic Myeloid Leukemia

OSUWexnerbloglogo2014CME Webcast Discusses Acute and Chronic Myeloid Leukemia. Joining our webcast to tell you all about the newest developments in chronic myelogenous leukemia is hematologist and Assistant Professor of Internal Medicine from the Ohio State University, Dr. Katherine Walsh. And then to tell you about acute myeloid leukemia is OSU hematologist and also Assistant Professor of Internal Medicine, Dr. Alice Mims.

View a video introduction of this webcast

What you’ll learn in this webcast

As a result of this educational activity, webcast participants will be able to: REVIEW the clinical presentation and diagnosis of CML; REVIEW the front line treatment options and milestones for response to treatment; DESCRIBE the clinical presentation and diagnosis of AML.

You’ll also learn about the following:

  • Presenting signs and symptoms of CML
  • Presenting signs and symptoms of AML
  • Stem cell transplant in CML
  • Initial evaluation and management of patients with suspected AML
  • Initial treatment of patients with AML
  • CML blast crisis
  • Leukemoid reaction versus CML
  • Which patients with AML require a lumbar puncture
  • Which patients with AML need a permanent venous catheter

You can find this and many other MedNet21 programs on the OSU – CCME website.

Call our MedNet21 Program Manager at 614.293.3473 for more details about subscribing to MedNet21 as a hospital or as an individual. You can also e-mail him at derrick.freeman@osumc.edu.